GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zura Bio Ltd (NAS:ZURA) » Definitions » Price-to-Tangible-Book

Zura Bio (Zura Bio) Price-to-Tangible-Book : 3.47 (As of May. 10, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Zura Bio Price-to-Tangible-Book?

As of today (2024-05-10), Zura Bio's share price is $4.7267. Zura Bio's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $1.36. Hence, Zura Bio's Price to Tangible Book Ratio of today is 3.47.

The historical rank and industry rank for Zura Bio's Price-to-Tangible-Book or its related term are showing as below:

ZURA' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.36   Med: 3.43   Max: 3.49
Current: 3.48

During the past 3 years, Zura Bio's highest Price to Tangible Book Ratio was 3.49. The lowest was 3.36. And the median was 3.43.

ZURA's Price-to-Tangible-Book is ranked worse than
57.4% of 1223 companies
in the Biotechnology industry
Industry Median: 2.75 vs ZURA: 3.48

A closely related ratio is called PB Ratio. As of today, Zura Bio's share price is $4.7267. Zura Bio's Book Value per Sharefor the quarter that ended in Dec. 2023 was $1.36. Hence, Zura Bio's P/B Ratio of today is 3.47.


Zura Bio Price-to-Tangible-Book Historical Data

The historical data trend for Zura Bio's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zura Bio Price-to-Tangible-Book Chart

Zura Bio Annual Data
Trend Dec21 Mar22 Dec23
Price-to-Tangible-Book
- - 3.43

Zura Bio Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only - 14.49 5.13 4.50 3.43

Competitive Comparison of Zura Bio's Price-to-Tangible-Book

For the Biotechnology subindustry, Zura Bio's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zura Bio's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zura Bio's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Zura Bio's Price-to-Tangible-Book falls into.



Zura Bio Price-to-Tangible-Book Calculation

Zura Bio's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=4.7267/1.361
=3.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Zura Bio Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Zura Bio's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Zura Bio (Zura Bio) Business Description

Traded in Other Exchanges
Address
4225 Executive Square, Suite 600, La Jolla, CA, USA, 92037
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.
Executives
Parvinder Thiara director, 10 percent owner C/O TOURMALINE BIO, INC., 27 WEST 24TH STREET, SUITE 702, NEW YORK NY 10010
Amit Munshi director C/O EPIRUS BIOPHARMACEUTICALS, INC., 699 BOYLSTON STREET, 8TH FLOOR, BOSTON MA 02116
Graham Neil Murray Hamilton director 33 MT. GREEN RD, CROTON ON HUDSON, NEW YORK NY 10520
Sandeep Chidambar Kulkarni director 92 MORNINGSIDE AVE., APT 7E, NEW YORK NM 10027
Kimberly Ann Davis officer: Secretary and General Counsel C/O ZURA BIO INC., 4225 EXECUTIVE SQUARE, SUITE 600, LA JOLLA CA 92037
Gary Whale officer: EVP and CTO 2 THE BEACHES, SHIPLAKE, HENLEY-ON-THAMES, OXFORDSHIRE X0 RG9 3BT
Theresa Lowry officer: EVP and CHRO 3629 VILLA TERRACE, SAN DIEGO CA 92104
Michael Howell officer: SVP, Translational Medicine 4225 EXECUTIVE SQUARE, SUITE 600, LA JOLLA CA 92037
Hana Immunotherapeutics Llc 10 percent owner 6 CENTERPOINTE DR., #625, LA PALMA CA 90623
Chris Kim 10 percent owner 6 CENTERPOINTE DR., #625, LA PALMA CA 90623
Ewon Comfortech Co., Ltd. 10 percent owner 8, CHEOMDAN 1-RO, JEONGUP-SI, JEONLABUK-DO M5 320836
Steven J Schoch director 2748 BUSH STREET, SAN FRANCISCO CA 94115
Preston Klassen officer: President and COO 3344 N. TORREY PINES COURT, SUITE 200, LA JOLLA CA 92037
Christopher Cabell officer: EVP and CMO C/O ARENA PHARMACEUTICALS, INC., 6154 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
Jennifer Jarrett director C/O MEDIVATION, INC., 525 MARKET ST., 36TH FLOOR, SAN FRANCISCO CA 94105